Invesco
ALXO icon

Invesco’s ALX Oncology ALXO Stock Holding History

Invesco’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22K Buy
+10,980
New +$20.9K ﹤0.01% 3724
2025
Q2 		– Sell
-73,836
Closed -$46K – 3766
2025
Q1 		$46K Buy
+73,836
New +$88.6K ﹤0.01% 3704
2024
Q3 		– Sell
-10,290
Closed -$62K – 3756
2024
Q2 		$62K Buy
+10,290
New +$127K ﹤0.01% 3800
2024
Q1 		– Sell
-385,232
Closed -$5.74M – 3863
2023
Q4 		$5.74M Buy
+385,232
New +$3.65M ﹤0.01% 2167
2022
Q2 		– Sell
-643,487
Closed -$10.9M – 4037
2022
Q1 		$10.9M Buy
643,487
+13,565
+2% +$232K ﹤0.01% 1915
2021
Q4 		$13.5M Buy
629,922
+115,107
+22% +$4.96M ﹤0.01% 1816
2021
Q3 		$38M Buy
514,815
+507,399
+6,842% +$33.8M 0.01% 1168
2021
Q2 		$406K Buy
7,416
+4,225
+132% +$253K ﹤0.01% 3506
2021
Q1 		$235K Buy
+3,191
New +$251K ﹤0.01% 3640

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Invesco's ALXO Position: Q1 2026 in Review

Invesco opened a new position in ALX Oncology (ALXO) in Q1 2026: 10,980 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #3724 among its holdings. This is a return to the name: Invesco previously reported a position in ALXO as recently as Q1 2025.

Invesco first reported a position in ALXO in Q1 2021 and has held it in 9 quarters since. The position peaked at $38M in Q3 2021. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.

  • Invesco held 10,980 shares of ALX Oncology worth $22K as of Q1 2026.
  • ALX Oncology was a new Invesco position in Q1 2026.
  • ALX Oncology made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3724 holding.
  • Invesco first reported a position in ALX Oncology in Q1 2021 and has held it in 9 quarters since.
  • Invesco's ALX Oncology position peaked at $38M in Q3 2021.
  • 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.